CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
A Multicenter, Prospective, Randomized, Comparison IDE Study Between the Pulse Biosciences CellFX System and Cryosurgery for the Treatment of Cutaneous Non-Genital Common Warts
Sponsor: Pulse Biosciences, Inc.
This NA trial investigates Verruca and Warts and is currently completed. Pulse Biosciences, Inc. leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Dec 2023 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2021 — Dec 2022 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Mar 2021 — Sep 2021 [monthly]
Recruiting NA
First recorded
Feb 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pulse Biosciences, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .